Literature DB >> 3013659

Effects of atriopeptins on relaxation and cyclic GMP levels in human coronary artery in vitro.

R M Rapoport, R Ginsburg, S A Waldman, F Murad.   

Abstract

The effects of atriopeptins on relaxation and cyclic GMP levels were examined in human coronary artery. alpha-Atrial natriuretic polypeptide and atriopeptins I, II and III all induced relaxation. Relaxations to atriopeptin I were of a smaller magnitude. The atriopeptins elevated cyclic GMP levels from 2- to 3-fold. These studies suggest that atriopeptins released from the heart may dilate the vasculature of this organ and increase coronary blood flow through the formation of cyclic GMP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013659     DOI: 10.1016/0014-2999(86)90144-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Presence of immunoreactive atrial natriuretic peptide in nerve fibres and conduction cells in the conduction system of the bovine heart.

Authors:  M Hansson; S Forsgren
Journal:  Anat Embryol (Berl)       Date:  1993-10

2.  Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery.

Authors:  K E Wiley; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

3.  Different effects of alpha-human atrial natriuretic peptide and nitroglycerin on cardiac dimensions in humans.

Authors:  T Imaizumi; A Takeshita; M Yoshida; S Suzuki; S Ando; Y Hirooka; M Nakamura
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

4.  The effect of atrial natriuretic peptide on human isolated resistance arteries.

Authors:  A D Hughes; H Nielsen; P S Sever
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

5.  Atrial natriuretic factor in the impulse-conduction system of rat cardiac ventricles.

Authors:  M Cantin; G Thibault; H Haile-Meskel; J Ding; R W Milne; M Ballak; C Charbonneau; M Nemer; J Drouin; R Garcia
Journal:  Cell Tissue Res       Date:  1989       Impact factor: 5.249

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.